New eczema ointment shows promise in early trial

NCT ID NCT06309355

Completed Symptom relief Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new ointment called YR001 in 35 adults with mild to moderate atopic dermatitis (eczema). The main goal was to check if the ointment is safe and how the body processes it. Researchers also looked at whether it improves skin condition. The trial was completed and placebo-controlled.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Locations

DelRicht Research

Baton Rouge, Louisiana, 70809, United States
Encore Medical Research -Boynton Beach

Boynton Beach, Florida, 33436, United States
Encore Medical Research-Hollywood

Hollywood, Florida, 33331, United States
Encore Medical Research-Weston

Weston, Florida, 33331, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.